Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

84.95
+0.11000.13%
Post-market: 84.970.0200+0.02%19:49 EDT
Volume:8.21M
Turnover:697.41M
Market Cap:9.01B
PE:-16.89
High:85.01
Open:84.96
Low:84.92
Close:84.84
52wk High:85.01
52wk Low:31.00
Shares:106.10M
Float Shares:95.53M
Volume Ratio:8.52
T/O Rate:8.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0290
EPS(LYR):-4.9500
ROE:-42.45%
ROA:-26.28%
PB:7.56
PE(LYR):-17.16

Loading ...

Crinetics Pharmaceuticals - Co May Pay Termination Fee of $350.47 Mln to Vertex if Deal is Terminated Under Certain Circumstances - SEC Filing

THOMSON REUTERS
·
Jul 07

Crinetics Shares More than Doubles in After Market Trade After Vertex Announces $10 Billion Acquisition Deal, Last up 101% at $84.80

THOMSON REUTERS
·
Jul 07

Vertex to acquire Crinetics for $85 per share in cash

TIPRANKS
·
Jul 07

Vertex to Buy Crinetics for $85 Per Share in Cash, Valuing Deal at $10 Billion

Reuters
·
Jul 07

Crinetics Pharmaceuticals: Financing Supported by $4.5 Bln of Fully Committed Bridge Financing from Bank of America, Morgan Stanley Senior Funding

THOMSON REUTERS
·
Jul 07

Crinetics Pharmaceuticals: Deal Expected to be Accretive Vertex's to Non-gaap Operating Income in 2029

THOMSON REUTERS
·
Jul 07

Crinetics Pharmaceuticals Inc: Vertex Will Acquire Crinetics for $85.00 Per Share in Cash

THOMSON REUTERS
·
Jul 07

DLocal, Cypherpunk, BCE, LAC, Crinetics: Trending By Analysts

TIPRANKS
·
Jul 04

Sector Update: Healthcare

MT Newswires Live
·
Jul 03

Crinetics Pharmaceuticals Shares Rise After UBS Initiates Coverage

MT Newswires Live
·
Jul 03

UBS Initiates Coverage on Crinetics Pharmaceuticals With Buy Rating, $55 Price Target

MT Newswires Live
·
Jul 02

Crinetics Pharmaceuticals Initiated at Buy by UBS

Dow Jones
·
Jul 02

Crinetics initiated with a Buy at UBS

TIPRANKS
·
Jul 02

Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Definium Therapeutics (DFTX)

TIPRANKS
·
Jun 29

Crinetics Pharmaceuticals shareholders elect three Class II directors at annual meeting

Reuters
·
Jun 23

Crinetics Pharmaceuticals (CRNX) Stock Could Be 56.5% Undervalued After ENDO 2026 Data

Simply Wall St.
·
Jun 19

Crinetics director Stephanie Okey disposes of 6,900 shares worth $247,127.44

Reuters
·
Jun 19

How New Atumelnant and PALSONIFY Data At Crinetics Pharmaceuticals (CRNX) Has Changed Its Investment Story

Simply Wall St.
·
Jun 17

Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Pharvaris (PHVS)

TIPRANKS
·
Jun 16

Crinetics Pharmaceuticals Price Target Maintained With a $81.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 15